2024-10-29 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Analysis Report

**1. Performance Comparison:**

Teladoc Health Inc (TDOC) has underperformed the S&P 500 (VOO) significantly.  While the S&P 500 has gained 134.88%, TDOC has only increased by 52.57%, resulting in a **cumulative return difference of -82.31%.** This places TDOC at the 5th percentile in terms of relative performance compared to the S&P 500 historically, indicating that it has lagged behind significantly in recent years.

**2. Recent Price Movement:**

The stock closed at **$9.18** on the last market day. Here's a summary of recent price movement:

* **5-Day Moving Average:** $8.81
* **20-Day Moving Average:** $9.08
* **60-Day Moving Average:** $8.14

TDOC's price is currently trading above its 5-day and 20-day moving averages, suggesting short-term bullish sentiment. However, it's still below the 60-day moving average, indicating potential for further upside in the near future.

**3. Technical Indicators:**

* **RSI:** 55.19. This indicates that the stock is currently in a neutral territory, neither overbought nor oversold.
* **PPO:** -1.12.  A negative PPO suggests that the stock price momentum is weakening.
* **Delta_Previous_Relative_Divergence:** -0.38. This indicates a short-term downtrend in the relative price movement compared to its previous performance.
* **Expected Return:** 0.0%.  This indicates that the stock is expected to deliver similar returns to the S&P 500 over the long term (2 years or more) based on historical performance.

**4. Recent Earnings and Outlook:**

The latest earnings report (2024-08-01) showed an EPS of -4.92 and revenue of $0.64 billion. Although the revenue is relatively stable, the EPS remains negative, indicating ongoing financial challenges. 

Here's a summary of recent earnings data:

| Date         | EPS     | Revenue      |
|--------------|---------|---------------|
| 2024-08-01   | -4.92   | $0.64B        |
| 2024-04-26   | -0.49   | $0.65B        |
| 2023-10-27   | -0.35   | $0.66B        |
| 2023-07-28   | -0.40   | $0.65B        |
| 2023-04-28   | -0.40   | $0.65B        |

**5. Financial Trend Analysis:**

| Item               | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|--------------------|---------------|---------------|---------------|
| Revenue            | $0.64B          | $0.65B          | $0.66B          | 
| Gross Profit       | $0.45B          | $0.45B          | $0.47B          | 
| Gross Margin %     | 70.73%          | 69.89%          | 70.72%          | 
| Operating Income   | $-0.05B         | $-0.08B         | $-0.03B         | 
| Operating Margin % | -7.66%          | -11.93%         | -4.53%          | 
| Net Income         | $-0.84B         | $-0.08B         | $-0.03B         | 
| Net Margin %       | -130.39%        | -12.67%         | -4.37%         | 
| EPS                | $-4.89          | $-0.48          | $-0.17          | 
| ROE %              | -55.77%         | -3.58%          | -1.24%          | 
| Total Assets       | $3.52B          | $4.32B          | $4.39B          | 
| Total Liabilities  | $2.02B          | $2.03B          | $2.07B          | 
| Total Equity       | $1.50B          | $2.29B          | $2.33B          | 
| Operating Cash Flow | $0.09B          | $0.01B          | $0.13B          | 
| Capital Expenditure | $-0.03B         | $-0.04B         | $-0.04B         | 

The company shows steady revenue growth, with a consistent gross margin, but the operating income and net income remain negative. This signals a challenging financial landscape where the company faces significant operating and net income losses. 

**6. News and Recent Issues:**

Please provide the specific date for which you want the news analysis, and I can analyze recent earnings news from sources like Shacknews and provide insights on recent market outlook, analyst opinions, and performance highlights. 

**7. Summary and Conclusion:**

Teladoc Health Inc (TDOC) is a telemedicine company facing significant challenges. While it has shown stable revenue growth, the company continues to struggle with profitability, leading to negative EPS and net income. The stock has significantly underperformed the S&P 500, lagging behind in recent years. Technical indicators suggest a neutral sentiment with short-term bullishness. The expected return, however, is not promising, suggesting that long-term investors should be cautious. 

To make a well-informed investment decision, further research is recommended, including a deep dive into the company's future growth prospects, competitive landscape, and potential strategies to achieve profitability. 
